They also demonstrated a link between this upregulation and the tumor’s stage and metastatic potential, as well as a negative correlation between the expression of ANXA2 and E-cadherin, further proving that ANXA2 may contribute to metastasis in GAC, and that it can represent a potential target for treatment [66]. The gene discussed is ANXA2; the disease is neoplasm.